Camp4 Therapeutics (CAMP) Equity Average (2023 - 2025)
Historic Equity Average for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $49.3 million.
- Camp4 Therapeutics' Equity Average changed N/A to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year change of. This contributed to the annual value of -$30.3 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Camp4 Therapeutics' Equity Average stood at $49.3 million.
- In the past 5 years, Camp4 Therapeutics' Equity Average ranged from a high of $57.4 million in Q1 2025 and a low of -$117.6 million during Q4 2023
- In the last 3 years, Camp4 Therapeutics' Equity Average had a median value of $45.8 million in 2025 and averaged -$2.6 million.
- Examining YoY changes over the last 5 years, Camp4 Therapeutics' Equity Average showed a top increase of 5926.94% in 2024 and a maximum decrease of 5926.94% in 2024.
- Quarter analysis of 3 years shows Camp4 Therapeutics' Equity Average stood at -$117.6 million in 2023, then surged by 59.27% to -$47.9 million in 2024, then skyrocketed by 202.95% to $49.3 million in 2025.
- Its last three reported values are $49.3 million in Q3 2025, $45.8 million for Q2 2025, and $57.4 million during Q1 2025.